SG Pharma Solutions
SG PHARMASOLUTIONS
SG Pharma Solutions
SG PHARMASOLUTIONS
Knowledge Hub

Insights & Resources

Technical Resources & Regulatory Updates

Scientific updates, regulatory guidance interpretations, and technical methodologies to support your E&L and safety assessment workflows.

Why Most Extractables & Leachables Studies Fail Regulatory Review—and How to Fix ThemExpress Pharma
Industry PublicationJune 23, 2025

Why Most Extractables & Leachables Studies Fail Regulatory Review—and How to Fix Them

More than 60% of initial E&L submissions get flagged due to study design, regulatory interpretation, and documentation. Discover how targeted risk assessment, protocol design, and toxicological justification strengthen compliance.

Analytical & QualityNovember 2025
LinkedIn

E&L Studies: The Role of Blanks and Controls

Blanks & Controls are the unsung heroes of E&L studies. Solvent blanks reveal contamination, system blanks track instrument background, and positive controls verify method sensitivity. Without proper controls, even the best MS data is compromised.

Technical BriefMay 17, 2025
LinkedIn

Regulatory & Technical Insights: E&L Study Best Practices

Key technical considerations and regulatory interpretations for designing compliant, submission-ready Extractables & Leachables testing workflows for pharmaceutical container closure systems.

Toxicological SafetyMay 15, 2025
LinkedIn

Scientific Considerations for E&L Risk Assessment

Scientific methodologies and risk-based toxicological evaluations supporting pharmaceutical packaging, container closure, and medical device regulatory submissions.

RegulatoryAugust 2026
SG Pharma Solutions

Understanding ISO 10993-18 Requirements for Chemical Characterization

A technical breakdown of the recent updates to ISO 10993-18 and how they impact chemical characterization study designs for Class II and III medical devices.

ToxicologyJuly 2026
SG Pharma Solutions

Deriving PDE Limits for Complex Leachables

Best practices for toxicological risk assessment and deriving Permitted Daily Exposure (PDE) limits for unidentified or complex leachable compounds.

AnalyticalJune 2026
SG Pharma Solutions

Analytical Strategies for Single-Use Systems (SUS)

Addressing the unique analytical challenges of profiling extractables from large-scale bioprocessing equipment and single-use systems.